Literature DB >> 4029947

Ultrastructural and immunohistochemical characteristics of mucoepidermoid carcinoma of the breast.

W Hanna, H J Kahn.   

Abstract

Mucoepidermoid carcinoma is a rare subtype of breast carcinoma. In an attempt to elucidate the histogenesis of these tumors, two mucoepidermoid carcinomas were studied electron microscopically and immunohistochemically with antisera to S-100 protein and epidermal cytokeratin. Light microscopic examination showed these tumors to be composed of mixtures of neoplastic mucus-secreting, squamous, and intermediate cells. Ultrastructural examination revealed squamous cells, mucus-secreting luminal cells, and classic myoepithelial cells. The intermediate cells, which contained focal peripheral myofilaments with dense bodies and pinocytotic vesicles associated with centrally aggregated tonofilaments, were interpreted as modified myoepithelial cells. Classic dendritic myoepithelial and intermediate (modified myoepithelial) cells stained with antisera to S-100 protein and epidermal cytokeratin. Both the ultrastructural and the immunohistochemical features indicate that myoepithelial and duct luminal cells play an important role in the histogenesis of mucoepidermoid tumors of the breast.

Entities:  

Mesh:

Year:  1985        PMID: 4029947     DOI: 10.1016/s0046-8177(85)80133-7

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  10 in total

1.  Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study.

Authors:  S Gill; D Peston; B K Vonderhaar; S Shousha
Journal:  J Clin Pathol       Date:  2001-12       Impact factor: 3.411

Review 2.  Mucoepidermoid carcinoma in a breast affected by burn scars: comprehensive literature review and case report.

Authors:  Murat Basbug; Sami Akbulut; Zulfu Arikanoglu; Nilgun Sogutcu; Ugur Firat; Mehmet Kucukoner
Journal:  Breast Care (Basel)       Date:  2011-08       Impact factor: 2.860

3.  Comparative histogenesis and morphogenesis of mucoepidermoid carcinoma and pleomorphic adenoma. An ultrastructural study.

Authors:  I Dardick; M R Gliniecki; J G Heathcote; A Burford-Mason
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 4.  Mucoepidermoid carcinoma of the breast: A case report and literature review focused on radiological findings.

Authors:  Seongjun Bak; Hye Young Choi; Jeong-Hee Lee; Jae Beom Na; Dae Seob Choi; Jae Min Cho; Ho Cheol Choi; Mi Jung Park; Ji Eun Kim; Hwa Seon Shin; Jung Ho Won; Ju-Yeon Kim; Jae-Myung Kim
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

Review 5.  Salivary gland-like tumours of the breast: surgical and molecular pathology.

Authors:  M Pia-Foschini; J S Reis-Filho; V Eusebi; S R Lakhani
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

6.  Mucoepidermoid carcinoma of the breast.

Authors:  Luca Di Tommaso; Maria P Foschini; Teresa Ragazzini; Elisabetta Magrini; Adele Fornelli; Ian O Ellis; Vincenzo Eusebi
Journal:  Virchows Arch       Date:  2003-11-21       Impact factor: 4.064

Review 7.  Mucoepidermoid carcinoma of the pancreas: report of a case.

Authors:  N Onoda; S M Kang; S Sugano; Y Yamashita; Y S Chung; M Sowa
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

8.  Novel therapeutic strategies for malignant salivary gland tumors: lessons learned from breast cancer.

Authors:  Ryuichi Murase; Tomoki Sumida; Akiko Ishikawa; Rumi Murase; Sean D McAllister; Hiroyuki Hamakawa; Pierre-Yves Desprez
Journal:  Int J Otolaryngol       Date:  2011-11-21

9.  Clinicopathologic features of triple negative breast cancers: an experience from Pakistan.

Authors:  Atif Ali Hashmi; Muhammad Muzzammil Edhi; Hanna Naqvi; Naveen Faridi; Amna Khurshid; Mehmood Khan
Journal:  Diagn Pathol       Date:  2014-02-28       Impact factor: 2.644

Review 10.  Mucoepidermoid carcinoma of the breast: Four case reports and review of the literature.

Authors:  Meng Cheng; Cuizhi Geng; Tiantian Tang; Zhenchuan Song
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.